How Long Does a Molly High Last?

The main effects run 3 to 5 hours, peaking around 1.5 to 2.5 hours after you swallow it. That is the part people mean by “how long does it last.”

The honest answer is longer. Residual stimulation, emotional sensitivity and disrupted sleep commonly run 8 to 24 hours, and MDMA’s half-life of roughly 7 to 8 hours means the drug is still in your bloodstream well after you stop feeling it. Plan for a day, not an evening.

The timeline, hour by hour

T+0:00, ingestion. Nothing yet. MDMA absorbs through the gut, and how fast depends heavily on what is already in your stomach.

T+0:20 to T+0:45, first alert. Mild warmth, a light tingle, restlessness, heightened awareness. Brief nausea is common as the drug enters circulation, and a few people feel anxious here. That is the come-up, not a warning sign. Do not redose in this window. You have not felt what the dose does yet.

T+0:45 to T+1:30, onset. Effects become unmistakable: emotional openness, warmth toward people, heightened senses, tactile sensitivity. Jaw tension often starts here, along with dilated pupils, raised heart rate and a small temperature rise. MDMA works by triggering rapid release of serotonin, dopamine and norepinephrine, and serotonin stores start depleting from this point. That depletion is why the peak eventually fades and why redosing gives diminishing returns.

T+1:30 to T+2:30, peak. The most intense phase. Euphoria, empathy and energy at their highest, music and touch and conversation richly amplified. Jaw clenching usually peaks here too, which our magnesium and jaw clenching guide covers.

De la Torre and Farré’s 2000 pharmacokinetic work in the British Journal of Clinical Pharmacology put peak plasma concentrations at roughly 1.5 to 2.5 hours post-ingestion for standard doses. Peak subjective effects track peak plasma levels closely, which is unlike LSD, where tight receptor binding sustains the experience after blood levels have already dropped.

T+2:30 to T+4:00, plateau. Sustained but no longer building. Many people find this the most socially rewarding stretch: connected, talkative, emotionally clear. It will feel less strong than the peak did. That is serotonin depletion, not a reason to redose.

T+4:00 to T+5:00, descent. Energy fades first, then the empathogenic quality. Emotional sensitivity often rises as euphoria recedes, and feeling briefly raw or tender is normal.

T+5:00 to T+24:00, afterglow and comedown. From roughly T+5 to T+8 some people feel pleasantly tired and reflective, a mild positive carry-over as serotonin normalises. From T+8 to T+24 the comedown can bring fatigue, low mood, flatness or irritability from temporary serotonin depletion. Not everyone gets a significant one; dose, use frequency and individual neurochemistry all matter.

Sleep is its own problem. Most people cannot sleep for 4 to 8 hours after effects end, because of norepinephrine release and residual stimulation. Around T+8 to T+10 sleep usually becomes possible, though often restless. See how to sleep after a rave, and the comedown guide for the grey day afterwards.

Redosing does not do what people think

A second dose taken 90 minutes or more into the experience adds roughly 1.5 to 2 hours of effects, not another 4 to 5. Serotonin stores are already depleted, so there is not enough substrate left to reproduce the first wave.

Each redose also worsens the next day roughly in proportion to how much extra you took.

The trap is the T+2:30 to T+3:00 window, where effects feel weaker and the impulse is to top up. That weakening is the depletion starting. More MDMA will not restore the T+1:30 feeling. It will stretch a diminished version out and make tomorrow worse.

If you are going to redose anyway: once, at half the original dose or less, before the peak has fully ended.

What actually changes the duration

Dose is the biggest lever. 75 mg may run 3 hours where 150 mg pushes past 5. Higher doses do not only intensify the experience, they lengthen it and speed up depletion. Our MDMA dosing guide has ranges by body weight.

Stomach contents change onset, not duration. Empty stomach shortens onset to 20 to 30 minutes; a full meal pushes it to 75 to 90.

Route matters. Insufflation comes on faster, 15 to 30 minutes, but runs slightly shorter, and bioavailability differences mean you effectively get less of what you took.

CYP2D6 varies between people. MDMA is metabolized mainly by CYP2D6, and roughly 5 to 10% of people are poor metabolizers who get higher peak plasma levels, longer duration and more adverse effects from the same dose. There is no way to know in advance without genetic testing.

Heat and dancing. A hot room accelerates distribution and raises hyperthermia risk, which is the leading cause of MDMA deaths. Drink around 500 mL of water per hour if you are dancing, around 250 mL per hour if you are not. Overhydration causing hyponatremia is a documented risk in the other direction, so do not drink past what you need.

Body weight affects distribution volume slightly, well behind dose and metabolism.

Planning around it

If you dose at 9 PM, expect to be awake until 3 to 5 AM at minimum, so block out the day rather than the evening.

Do not drive for at least 8 hours after ingestion, and 12 is safer. Reaction time, judgement and pupil dilation all persist long past the point where you feel normal.

Keep the next day clear if you can. The comedown day is real even when it is mild.

And all of the timing above assumes you know what you took. A pill or powder that is not MDMA has a different timeline entirely, which is the most common reason someone’s experience does not match a guide like this one.

For effects, risks and safer-use practice in full, see our MDMA harm reduction guide. Combining with anything, including alcohol, check the interaction guide first.

Sources

• de la Torre R, Farré M, et al. Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. British Journal of Clinical Pharmacology, 2000. PMID 10671903
• Plasma pharmacokinetics of MDMA after controlled oral administration to young adults. Therapeutic Drug Monitoring, 2008. PMID 18520604
• A review of the acute subjective effects of MDMA/ecstasy. Addiction, 2006. PMID 16771886